It's a British-themed day here at GTO. As if the Wellcome Trust's protein decorations weren't enough, here's an article from today's Guardian reporting that business leaders are warning that British investment in science has been too low to keep it at the forefront. According to the article:

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor among brittle stars, single-cell RNA sequencing strategy, and more.